Download the white paper courtesy of Precision for Medicine here >>
Precision for Medicine is a proud sponsor of World Precision Medicine Congress USA 2016, taking place November 14-15 in Washington D.C. Its not too late to join them - register now >>
Don't miss Chad Clark's (President, Precision for Medicine) presentations on "
Precision approvals: How biomarkers are blurring the lines in clinical trials and accelerating commercial launch"
at 9.30 on the 15th.
-
Biomarker driven patient stratification is bending the curve away from traditional Phase I, II and III studies– leading to accelerated approvals based on fewer patients, earlier
-
Understanding the scientific, logistical and practical changes in design and execution of clinical trials for precision medicine – including adaptive designs, patient stratification technologies, biospecimen considerations, and site selection
-
Demonstrating value to payers and hospital systems and the healthcare system implications of every disease becoming a rare disease